You’re here because you want a weight care solution that works with your biology. We’ve got you—with personalized treatment plans and access to prescriptions for a wide toolkit of medications*, we partner with you to create sustainable change.

Every body is different, and so is the medication that will help unlock your weight loss goals. We’re continuing to build our medication toolkit and are happy to announce that Zepbound® has been added to our prescription lineup. Studies show this FDA-approved medication helps people lose weight by regulating insulin, balancing blood sugar, and reducing appetite. In one clinical trial of 2,539 adults, those taking the highest dose (15 mg) lost an average of 48 pounds, and those on the lowest dose (5 mg) lost an average of 34 pounds.

Ready to learn more about the latest addition to our medication toolkit? Right this way.

Ready for lasting results?

For a limited time only, get $20 off your first month on Found**. 

Use this code at checkout:

NC-20DOFM

REMINDER:

For a limited time only, get $20 off your first month on Found**. 

Use this code at checkout:

NC-20DOFM

A massive shift is occurring as new weight loss drugs hit the shelves and we learn more about how biology influences body weight: There are now more options for treatment. Zepound® and Wegovy® are two of the latest FDA-approved drugs on the market to treat severe obesity and chronic weight management. Is one better for you than the other? Click the link below to learn all you need to know about Zepbound vs Wegovy.

Before Zepbound’s® approval, semaglutide, sold under the brand name Ozempic®, was considered a first-line anti-obesity medication. However, new studies suggest Zepbound may offer even more significant weight loss results than Ozempic.

So, when it comes to Zepbound vs Ozempic, how are they different? How do they work? Which one is more affordable? And will Zepbound become today’s most sought-after prescription weight loss drug? Learn more by clicking the link below.

We hear you loud and clear! Zepbound manufacturer Eli Lilly created the Zepbound Savings Card program to make the drug more affordable for those who need it most. If you’re interested in finding out more, we’ve got you covered. Here’s info to learn how you can check your eligibility in three simple steps. 

Ready for lasting results?

For a limited time only, get $20 off your first month on Found**. 

Use this code at checkout:

NC-20DOFM

With Found, results don't just last a month or six. They're also not superficial. The basis of our approach is designed to work in partnership with your mind, body, stomach, biology, hormones, and all. We don't force our members into one singular solution because that's simply not how bodies work. Instead, we adjust our team, medicine, technology, and techniques to meet you where you are.

Dr. Rekha Kumar

Chief Medical Officer - Found

Find the Found plan that's right for you

Copyright @ 2024 Found Inc.

1023 Springdale Rd, Suite 13A
Austin, TX 78721

privacy policy

We sent you this email because you asked for updates about new products and promotions. If you'd rather not receive email updates from us, you can unsubscribe from our mailing list by clicking Unsubscribe.

*Certain medications are FDA approved for conditions other than weight loss. Prescriptions are up to a medical provider’s discretion. Visit www.joinfound.com for additional risk information.

**Offer is valid only toward self-pay subscriptions and cannot be used to discount medical visits or medications. Offer cannot be combined with any other promotion, offer, or coupon. Offer cannot be applied to past purchases, redeemed for cash equivalent used to purchase gift cards, or used as payment on an account. Offer is not available to individuals who receive a Found subscription through a group or association (e.g. through an employer) or to individuals whose health insurance plan pays for some or all of Found’s services. Found reserves the right to cancel this offer at any time and to cancel orders arising from pricing, technical, or other errors.